Researcher Profile Statistics: Tang Ming Yi Richard
Geo Map
Region
#
NA - North America
52
AS - Asia, other
19
EU - Europe
9
Unknown
7
Total
87
Country
#
US - United States of America
52
IN - India
8
IE - Ireland
6
SG - Singapore
4
CN - China
3
BD - Bangladesh
1
CH - Switzerland
1
DE - Germany
1
HK - Hong Kong
1
IR - Iran
1
other - Other Country
9
Total
87
City
#
Washington
20
Springfield
5
Vellore
3
Ashburn
2
Dodge
2
Singapore
2
Brovary
1
Central
1
Chennai
1
Davao City
1
other
49
Total
87
Bitstream
Downloads
ID: 1482890 - Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine.pdf - ITEM:( 10635/239239)
42
Total: {0}
42
Most bitstream per type viewed
#
ID: other -
0
ID: journal -
87
ID: conference -
0
ID: patent -
0
ID: allItems -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
87
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 0
0 0 2 1
0 1 0 2
0 1
7
2024
1 0
2 4 15 14
9 23 12 0
0 0
80
Ever
87
Geo Map
Region | # |
---|---|
NA - North America | 52 |
AS - Asia, other | 19 |
EU - Europe | 9 |
Unknown | 7 |
Total | 87 |
Country | # |
---|---|
US - United States of America | 52 |
IN - India | 8 |
IE - Ireland | 6 |
SG - Singapore | 4 |
CN - China | 3 |
BD - Bangladesh | 1 |
CH - Switzerland | 1 |
DE - Germany | 1 |
HK - Hong Kong | 1 |
IR - Iran | 1 |
other - Other Country | 9 |
Total | 87 |
City | # |
---|---|
Washington | 20 |
Springfield | 5 |
Vellore | 3 |
Ashburn | 2 |
Dodge | 2 |
Singapore | 2 |
Brovary | 1 |
Central | 1 |
Chennai | 1 |
Davao City | 1 |
other | 49 |
Total | 87 |
Bitstream | Downloads |
---|---|
ID: 1482890 - Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine.pdf - ITEM:( 10635/239239) | 42 |
Total: {0} | 42 |
Most bitstream per type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 87 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: allItems - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 87 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 2 | 0 | 1 | 7 |
2024 | 1 | 0 | 2 | 4 | 15 | 14 | 9 | 23 | 12 | 0 | 0 | 0 | 80 |
Ever | 87 |